< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

4 clusters · 20 sources · 21 days · First seen · Last updated

Categories: BUSINESS

Philip Morris earnings, forecast cut, IQOS & Zyn growth

Entities: Philip Morris International · Aurora, Colorado · Clough Capital Partners L.P. · Zyn nicotine pouches · Global Travel Retail

Overview

In early July 2026, Philip Morris International posted first‑quarter earnings of $1.96 per share on $10.15 billion revenue and later reported second‑quarter revenue of $11.2 billion, with the smoke‑free segment rising 11.7% to about 42% of sales. Adjusted EPS reached $2.20, but the full‑year profit outlook was trimmed to $8.26‑$8.41 per share amid stronger competition in nicotine‑pouch products and adverse currency effects.

The company accelerated its U.S. Zyn portfolio after FDA approval of new variants and, in late July, confirmed that its Aurora, Colorado campus will receive a $1.2 billion investment through 2028—double the original commitment. The 780,000‑square‑foot, 148‑acre facility, which began full commercial production in July 2026, will supply Zyn pouches for domestic use and export to Asia, Latin America and the Caribbean, creating roughly 500 direct and 1,000 indirect jobs and an estimated $550 million annual economic impact.

IQOS continued to gain market share, achieving a 21.5% off‑take in global travel‑retail airports. Institutional activity included Clough Capital Partners acquiring about 50,000 PMI shares. PMI’s CEO highlighted momentum from the first half of the year and reaffirmed confidence in meeting annual targets, while noting industry‑wide shifts toward next‑generation nicotine products, as reflected in comparable growth reported by British American Tobacco.

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

Timeline

  1. 1 day ago

    [BUSINESS] 2 sources
    Philip Morris International invests $1.2 billion in US nicotine‑pouch plant

    Philip Morris International is investing $1.2 billion in a Colorado Zyn plant, creating 500 jobs and underscoring a shift to nicotine pouches, while British American Tobacco notes growth in its new‑category and

  2. 5 days ago

    [BUSINESS] 15 sources
    Philip Morris International raises Aurora, Colorado plant investment to $1.2 billion

    Philip Morris International doubled its Aurora, Colorado Zyn nicotine pouch plant investment to $1.2 billion, creating 500 jobs and $550 million annual economic impact while supporting export markets.

  3. 10 days ago

    [BUSINESS] 5 sources
    Philip Morris International posts 10% Q2 revenue growth, cuts annual profit forecast

    Philip Morris posted Q2 2026 revenue of $11.2 bn (up 10.4%), adjusted EPS $2.20, but cut its full‑year profit forecast to $8.26‑$8.41 per share amid tougher competition and currency hits, while expanding its Zy

  4. 22 days ago

    [BUSINESS] 2 sources
    Philip Morris International shares attract new buying and selling by institutional investors

    Institutional investors shifted positions in Philip Morris International, with Ibex buying ~30,940 shares and Summit selling most of its stake, as the company reported Q1 earnings of $1.96 EPS, $10.15 billion ‑

Sources

borse.it · calaboucodamorticiablog.wordpress.com · checkout.ie · coindeskjapan.com · coingape.com · crypto.news · elplural.com · finance.technews.tw · lavadome.org · mommygearest.com · okdiario.com · pulse2.com · seekingalpha.com · stocknews.com · stocktitan.net · theasset.nl · thecountersignal.com · wallstreetitalia.com · wixx.com · wtvbam.com

This summary has been updated 3 times: see revision history